1. Home
  2. Medical Devices & Consumables
  3. Global Market Analysis Of In-Vitro Colorectal Cancer Screening Tests Market By Test Type And By Region (Global Market Forecast To 2025)

Global Market Analysis Of In-Vitro Colorectal Cancer Screening Tests Market By Test Type And By Region (Global Market Forecast To 2025)

Publication Month: Mar 2020 | No. of Pages: 125 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

The Global In-Vitro Colorectal Cancer market is estimated to reach $1,236 million by 2025 from $ 850 million in 2018; growing at a CAGR of 5.5% from 2020 to 2025.

In Vitro, techniques are performed outside of the body. Colorectal Cancer is a type of cancer that mainly affects colon and rectum. Treatment for colorectal cancer mainly depends upon the size, location, and stage of cancer.

There are mainly 3 screening tests:

  1. Biomarker Test
  2. CRC DNA Screening Test
  3. Fecal Occult Blood Test

Market Dynamics

The Global In-Vitro Colorectal Cancer market is primarily driven by factors such as the growing occurrences of cancer, increasing demand for diagnostic tools, favorable rules and regulations policies, growing focus on research and development, and technological innovation, are some of the major forces that drive the market.

Market Segmentation

The Global In-Vitro Colorectal Cancer Market is mainly classified based on Test Type and Region.

  • Based on Test Type, the market is further segmented into Biomarker test (Transferrin Assays, Tumor M2-PK Stool Test), CRC DNA screening test (Panel DNA Test and Methylated Gene Test), and Fecal Occult Blood test (Immuno- Fecal Occult Blood Agglutination Test, Immuno Fecal Occult Blood ELISA Test, Guaiac Fecal Occult Blood Stool Test, and Lateral Flow Immuno Fecal Occult Blood Test)

Regional Analysis

Based on geography, the Global In-Vitro Colorectal Cancer market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa

Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Global In-Vitro Colorectal Cancer Market, competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Global In-Vitro Colorectal Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2018-2025, this study provides the Global In-Vitro Colorectal Cancer sales, revenue, and market share for each player covered in this report.

The major players covered in Global In-Vitro Colorectal Cancer are Abbott Molecular Inc., Beckman Coulter Inc., Epigenomics AG Corporation, Siemens Healthcare, CompanianDX, Merck Millipore, BioMarCare Technologies Ltd., ExiQon, Mode Diagnostics, Randox Laboratories Ltd., R-Biopharm Incorporation, Kyowa Medex Co. Ltd., Immunostics Inc., GeneNews Ltd., OncoCyte Corporation-Biotime, Quest Diagnostic Incorporated, Sysmex Corporation, Eiken Chemical, Alere Inc., and other prominent players.

In-Vitro Colorectal Cancer Market Key Segments:

By Test Type

  • Biomarker Test
    • Transferrin Assays
    • Tumor M2-PK Stool Test
  • CRC DNA Screening Test
    • Panel DNA Test
    • Methylated Gene Test
  • Fecal Occult Blood Test
    • Immuno - Fecal Occult Blood Agglutination Test
    • Immuno Fecal Occult Blood ELISA Test
    • Guaiac Fecal Occult Blood Stool Test
    • Lateral Flow Immuno Fecal Occult Blood Test

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1 Market Overview

1.1 In-Vitro Colorectal Cancer Introduction

1.2 Market Analysis by Test Type

1.2.1 Overview: Global In-Vitro Colorectal Cancer Revenue by Test Type: 2018 VS 2021 VS 2025

1.2.2 Biomarker Test

1.2.2.1 Transferrin Assays

1.2.2.2 Tumor M2-PK Stool Test

1.2.3 CRC DNA Screening Test

1.2.3.1 Panel DNA Test

1.2.3.2 Methylated Gene Test

1.2.4 Fecal Occult Blood Test

1.2.4.1 Immuno Fecal Occult Blood Test Agglutination Test

1.2.4.2 Immuno Fecal Occult Blood Test ELISA Test

1.2.4.3 Guaiac Fecal Occult Blood Test Stool Test

1.2.4.4 Lateral Flow Immuno Fecal Occult Blood Test

1.3 Overview of Global In-Vitro Colorectal Cancer Market

1.3.1 Global In-Vitro Colorectal Cancer Market Status and Outlook (2018-2025)

1.3.2 North America (United States, Canada and Mexico)

1.3.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.3.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.3.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abbott Molecular Inc.

2.1.1 Abbott Molecular Inc. Details

2.1.2 Abbott Molecular Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Abbott Molecular Inc. SWOT Analysis

2.1.4 Abbott Molecular Inc. Product and Services

2.1.5 Abbott Molecular Inc. In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.2 Beckman Coulter Inc.

2.2.1 Beckman Coulter Inc. Details

2.2.2 Beckman Coulter Inc. Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Beckman Coulter Inc. SWOT Analysis

2.2.4 Beckman Coulter Inc. Product and Services

2.2.5 Beckman Coulter Inc. In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.3 Epigenomics AG Corporation

2.3.1 Epigenomics AG Corporation Details

2.3.2 Epigenomics AG Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Epigenomics AG Corporation SWOT Analysis

2.3.4 Epigenomics AG Corporation Product and Services

2.3.5 Epigenomics AG Corporation In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.4 Siemens Healthcare

2.4.1 Siemens Healthcare Details

2.4.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Siemens Healthcare SWOT Analysis

2.4.4 Siemens Healthcare Product and Services

2.4.5 Siemens Healthcare In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.5 CompanionDX

2.5.1 CompanionDX Details

2.5.2 CompanionDX Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 CompanionDX SWOT Analysis

2.5.4 CompanionDX Product and Services

2.5.5 CompanionDX In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.6 Merck Millipore

2.6.1 Merck Millipore Details

2.6.2 Merck Millipore Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Merck Millipore SWOT Analysis

2.6.4 Merck Millipore Product and Services

2.6.5 Merck Millipore In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.7 BioMarCare Technologies Ltd.

2.7.1 BioMarCare Technologies Ltd. Details

2.7.2 BioMarCare Technologies Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 BioMarCare Technologies Ltd. SWOT Analysis

2.7.4 BioMarCare Technologies Ltd. Product and Services

2.7.5 BioMarCare Technologies Ltd. In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.8 ExiQon

2.8.1 ExiQon Details

2.8.2 ExiQon Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 ExiQon SWOT Analysis

2.8.4 ExiQon Product and Services

2.8.5 ExiQon Ltd. In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020)

2.9 Mode Diagnostics

2.9.1 Mode Diagnostics Details

2.9.2 Mode Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Mode Diagnostics SWOT Analysis

2.9.4 Mode Diagnostics Product & Services

2.9.5 Mode Diagnostics In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020) 2.10 Randox Laboratories Ltd.

2.10.1 Randox Laboratories Ltd. Details

2.10.2 Randox Laboratories Ltd. Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Randox Laboratories Ltd. SWOT Analysis

2.10.4 Randox Laboratories Ltd. Product and Services

2.10.5 Randox Laboratories Ltd. In-Vitro Colorectal Cancer Sales, Price, Revenue, Gross Margin and Market Share (2018-2020) 2.11 Other Players

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global In-Vitro Colorectal Cancer Sales and Market Share by Manufacturer (2018-2020)

3.2 Global In-Vitro Colorectal Cancer Revenue and Market Share by Manufacturer (2018-2020)

3.3 Market Concentration Rate

3.3.1 Top 3 In-Vitro Colorectal Cancer Manufacturer Market Share in 2018 & 2020

3.3.2 Top 6 In-Vitro Colorectal Cancer Manufacturer Market Share in 2018 & 2020

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Regions

4.1.1 Global In-Vitro Colorectal Cancer Sales and Market Share by Regions (2018-2020)

4.1.2 Global In-Vitro Colorectal Cancer Revenue and Market Share by Regions (2018-2020)

4.2 North America In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

4.3 Europe In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

4.4 Asia-Pacific In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

4.5 South America In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

4.6 Middle East and Africa In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

5 North America by Country

5.1 North America In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Country

5.1.1 North America In-Vitro Colorectal Cancer Sales and Market Share by Country (2018-2020)

5.1.2 North America In-Vitro Colorectal Cancer Revenue and Market Share by Country (2018-2020)

5.2 United States In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

5.3 Canada In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

5.4 Mexico In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

6 Europe by Country

6.1 Europe In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Country

6.1.1 Europe In-Vitro Colorectal Cancer Sales and Market Share by Country (2018-2020)

6.1.2 Europe In-Vitro Colorectal Cancer Revenue and Market Share by Country (2018-2020)

6.2 Germany In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

6.3 UK In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

6.4 France In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

6.5 Russia In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

6.6 Italy In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific In-Vitro Colorectal Cancer Sales and Market Share by Regions (2018-2020)

7.1.2 Asia-Pacific In-Vitro Colorectal Cancer Revenue and Market Share by Regions (2018-2020)

7.2 China In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7.3 Japan In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7.4 Korea In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7.5 India In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7.6 Southeast Asia In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

7.7 Australia In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

8 South America by Country

8.1 South America In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Country

8.1.1 South America In-Vitro Colorectal Cancer Sales and Market Share by Country (2018-2020)

8.1.2 South America In-Vitro Colorectal Cancer Revenue and Market Share by Country (2018-2020)

8.2 Brazil In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

8.3 Argentina In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa In-Vitro Colorectal Cancer Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa In-Vitro Colorectal Cancer Sales and Market Share by Country (2018-2020)

9.1.2 Middle East & Africa In-Vitro Colorectal Cancer Revenue and Market Share by Country (2018-2020)

9.2 Saudi Arabia In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

9.3 Turkey In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

9.4 Egypt In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

9.5 South Africa In-Vitro Colorectal Cancer Sales and Growth Rate (2018-2020)

10 Global In-Vitro Colorectal Cancer Market Segment by Test Type

10.1 Global In-Vitro Colorectal Cancer Sales Market Share by Test Type (2018-2020)

10.2 Global In-Vitro Colorectal Cancer Revenue Market Share by Test Type (2018-2020)

10.3 Global In-Vitro Colorectal Cancer Price by Test Type (2018-2020)

11 Market Forecast

11.1 Global In-Vitro Colorectal Cancer Sales, Revenue and Growth Rate (2021-2025)

11.2 In-Vitro Colorectal Cancer Market Forecast by Regions (2021-2025)

11.2.1 North America In-Vitro Colorectal Cancer Market Forecast (2021-2025)

11.2.2 Europe In-Vitro Colorectal Cancer Market Forecast (2021-2025)

11.2.3 Asia-Pacific In-Vitro Colorectal Cancer Market Forecast (2021-2025)

11.2.4 South America In-Vitro Colorectal Cancer Market Forecast (2021-2025)

11.2.5 Middle East & Africa In-Vitro Colorectal Cancer Market Forecast (2021-2025)

11.3 In-Vitro Colorectal Cancer Market Forecast by Test Type (2021-2025)

11.3.1 Global In-Vitro Colorectal Cancer Sales Forecast by Test Type (2021-2025)

11.3.2 Global In-Vitro Colorectal Cancer Market Share Forecast by Test Type (2021-2025)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About Us

 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets